Biofil Chemicals & Pharmaceuticals (BOM:524396) Debt-to-Equity : N/A (As of Dec. 2023)

Biofil Chemicals & Pharmaceuticals Debt-to-Equity Chart

Biofil Chemicals & Pharmaceuticals Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
Debt-to-Equity		Get a 7-Day Free Trial					0.12	0.08	0.03	0.03	0.03

Biofil Chemicals & Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															N/A	0.03	N/A	0.03	N/A

Competitive Comparison of Biofil Chemicals & Pharmaceuticals's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Biofil Chemicals & Pharmaceuticals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biofil Chemicals & Pharmaceuticals's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofil Chemicals & Pharmaceuticals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Biofil Chemicals & Pharmaceuticals's Debt-to-Equity falls into.

Biofil Chemicals & Pharmaceuticals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Biofil Chemicals & Pharmaceuticals's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Biofil Chemicals & Pharmaceuticals's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofil Chemicals & Pharmaceuticals  (BOM:524396) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Biofil Chemicals & Pharmaceuticals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Biofil Chemicals & Pharmaceuticals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofil Chemicals & Pharmaceuticals (BOM:524396) Business Description